Tower Research Capital (TRC)’s Kiora Pharmaceuticals KPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.26K | Sell |
439
-1,746
| -80% | -$5.03K | ﹤0.01% | 4841 |
|
2025
Q1 | $6.58K | Buy |
2,185
+980
| +81% | +$2.95K | ﹤0.01% | 4031 |
|
2024
Q4 | $3.98K | Sell |
1,205
-749
| -38% | -$2.47K | ﹤0.01% | 4555 |
|
2024
Q3 | $7.15K | Buy |
+1,954
| New | +$7.15K | ﹤0.01% | 4073 |
|
2024
Q2 | – | Sell |
-465
| Closed | -$2.96K | – | 5866 |
|
2024
Q1 | $2.96K | Buy |
465
+1
| +0.2% | +$6 | ﹤0.01% | 4959 |
|
2023
Q4 | $2.18K | Sell |
464
-1
| -0.2% | -$5 | ﹤0.01% | 5261 |
|
2023
Q3 | $2.38K | Sell |
465
-2
| -0.4% | -$10 | ﹤0.01% | 5165 |
|
2023
Q2 | $2.7K | Buy |
467
+462
| +9,240% | +$2.68K | ﹤0.01% | 5142 |
|
2023
Q1 | $0 | Sell |
5
-470
| -99% | – | ﹤0.01% | 6075 |
|
2022
Q4 | $15K | Buy |
+475
| New | +$15K | ﹤0.01% | 3426 |
|
2022
Q3 | – | Sell |
-35
| Closed | -$6K | – | 6297 |
|
2022
Q2 | $6K | Buy |
35
+5
| +17% | +$857 | ﹤0.01% | 4933 |
|
2022
Q1 | $7K | Buy |
30
+29
| +2,900% | +$6.77K | ﹤0.01% | 4730 |
|
2021
Q4 | $1K | Sell |
1
-37
| -97% | -$37K | ﹤0.01% | 5847 |
|
2021
Q3 | $31K | Buy |
+38
| New | +$31K | ﹤0.01% | 3353 |
|
2021
Q1 | – | Sell |
-1
| Closed | -$2K | – | 5564 |
|
2020
Q4 | $2K | Sell |
1
-3
| -75% | -$6K | ﹤0.01% | 4892 |
|
2020
Q3 | $6K | Buy |
+4
| New | +$6K | ﹤0.01% | 4293 |
|
2017
Q2 | – | Hold |
0
| – | -$1K | – | 3151 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 2805 |
|
2016
Q4 | – | Hold |
0
| – | -$2K | – | 4145 |
|
2016
Q3 | – | Hold |
0
| – | -$3K | – | 3092 |
|
2016
Q2 | – | Hold |
0
| – | -$3K | – | 3711 |
|
2016
Q1 | – | Hold |
0
| – | – | – | 3118 |
|
2015
Q4 | – | Sell |
-2
| Closed | -$28K | – | 4789 |
|
2015
Q3 | $28K | Buy |
+2
| New | +$28K | ﹤0.01% | 1454 |
|